Business

Scott Rocklage: An Entrepreneur Who Follows His Own Path

Scott Rocklage is a managing partner of 5AM Ventures who joined up with the company as a venture partner in 2003 only to become a Managing partner by 2004. Read more: Scott Racklage | Bloomberg

Scott works with a spread of entrepreneurs from different fields of study, such as, medicine, science, or business to help them take the ideas in their head and create real world medicines that may treat conditions that have not been treated as of yet.

The idea for the name 5AM Ventures came from the companies early stage business expertise, which creatively matches the early hour of 5am with the truth that it deals with company formation.

Scott’s day to day work life changes, which means some days he is gearing up for Board meetings while other days he is studying cutting edge life science ideas or assisting portfolio companies with their management teams.

Scott Rocklage believes that entrepreneurs are better off following their own path rather than working for a fortune 500 company, and he actively encourages people to take risks and follow their own path. His organization skills allow him to prioritize and balance his schedule, and he strives to teach others to do the same.

If Scott were to start all over from the beginning, he says that he would focus more on team selection for new companies, but he would also stick to the same principles that have served his businesses well over the years, which are to stay true to what your business knows how to excel in and not focus on what are not strengths.

With over 30 years of experience in healthcare management, Scott Rocklage has assisted with the FDA approval of the drugs Omniscan™, Teslascan® and Cubicin®, and he also sat as CEO and Chairman of Cubist Pharmaceuticals. Learn more about Scott Rocklage: http://www.rennovia.com/team/scott-m-rocklage/ and http://5amventures.com/team/scott-m-rocklage-phd/

His time as Board Chairman for both Novira and Relypsa served those companies well, and now he sits as Board Chairman for Cidara, Kinestral, Rennovia where he offers his expertise and guidance.

Scott earned a Bachelors of Science in Chemistry from the University of Berkley, California and a Ph.D. from MIY in Chemistry.